BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18771425)

  • 1. Identification of a novel splicing mutation in the fibrinogen Aalpha chain gene leading to hypofibrinogenaemia in a Chinese pedigree.
    Chen H; Wang X; Su X; Yang F; Lu Y; Xu G; Dai J; Ding Q; Xi X; Wang H
    Haemophilia; 2009 Jan; 15(1):394-7. PubMed ID: 18771425
    [No Abstract]   [Full Text] [Related]  

  • 2. Two novel mutations at contiguous codons in the fibrinogen Bbeta chain associated with hypofibrinogenaemia.
    Davis RL; May S; Chunilal S; Brennan SO
    Thromb Haemost; 2009 May; 101(5):980-2. PubMed ID: 19404555
    [No Abstract]   [Full Text] [Related]  

  • 3. Inherited abnormalities of fibrinogen: 10-year clinical experience of an Italian group.
    Santacroce R; Cappucci F; Pisanelli D; Perricone F; Papa ML; Santoro R; Grandone E; Margaglione M
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):235-40. PubMed ID: 16651864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
    Davis RL; Homer VM; George PM; Brennan SO
    Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function.
    Undas A; Zdziarska J; Iwaniec T; Stepien E; Skotnicki AB; de Moerloose P; Neerman-Arbez M
    Thromb Haemost; 2009 May; 101(5):975-6. PubMed ID: 19404553
    [No Abstract]   [Full Text] [Related]  

  • 6. Substitution (γ335Trp→Arg) in fibrinogen Fremantle causes diminished γ chain expression and increased sialic acid content.
    Brennan SO; Davis RL
    Thromb Haemost; 2010 Dec; 104(6):1274-6. PubMed ID: 20838743
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel fibrinogen Aalpha chain mutation associated with afibrinogenaemia.
    Saravanan L; Brennan S; George P; Lowen R; Kirkland M; Campbell P
    Pathology; 2007 Oct; 39(5):519-20. PubMed ID: 17886104
    [No Abstract]   [Full Text] [Related]  

  • 8. [Type I hereditary antithrombin deficiency due to C2757T heterozygotic mutation in antithrombin gene].
    Zhou RF; Dai Q; Fu QH; Wang WB; Xue S; Ding QL; Hu YQ; Wang XF; Wang HL
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1640-2. PubMed ID: 16185535
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjacent substitutions (γ352Gly→Cys and 353Thr→Pro) in fibrinogen Ilam cause diminished γ chain expression.
    Brennan SO; Oliver J; Davis RL
    Thromb Haemost; 2011 Feb; 105(2):379-81. PubMed ID: 21057694
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel fibrinogen Bbeta chain frameshift mutation in a patient with severe congenital hypofibrinogenaemia.
    Xu X; Wu J; Zhai Z; Zhou R; Wang X; Wang H; Ding K; Sun Z; Ni H
    Thromb Haemost; 2006 Jun; 95(6):931-5. PubMed ID: 16732370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen Montreal: a novel missense mutation (Aa D496N) associated with hypofibrinogenaemia.
    Sheen CR; Brennan SO; Jabado N; George PM
    Thromb Haemost; 2006 Aug; 96(2):231-2. PubMed ID: 16894470
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypodysfibrinogenemia causing mild bleeding and thrombotic complications in a compound heterozygote of AalphaIVS4+1G>T mutation and Aalpha4841delC truncation (Aalpha(Perth)).
    Jayo A; Arnold E; González-Manchón C; Green D; Lord ST
    Thromb Haemost; 2009 Apr; 101(4):770-2. PubMed ID: 19350124
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypofibrinogenaemia associated with common gamma82Ala-->Gly mutation is not mediated by altered mRNA splicing.
    Brennan SO; Homer VM; Davis RL; Meyer M; George PM
    Thromb Haemost; 2006 Oct; 96(4):535-7. PubMed ID: 17003934
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel fibrinogen (B β401Gly→Val) presents as dys- or hypodysfibrinogenaemia due to alterations in sialic acid content.
    Brennan SO; Roncolato F
    Thromb Haemost; 2011 Sep; 106(3):551-3. PubMed ID: 21713329
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of a synonymous variant in exon 9 of the CD44 gene on pre-mRNA splicing in a family with osteoporosis.
    Vidal C; Cachia A; Xuereb-Anastasi A
    Bone; 2009 Oct; 45(4):736-42. PubMed ID: 19580891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biological features of 3 cases of hypofibrinogenemia associated with three different mutations (gamma Ala341Thr, Bbeta Tyr326Cys and Aalpha Asp496Asn).
    Hanss M; Chevreaud C; French P; Négrier C; de Mazancourt P
    Thromb Haemost; 2007 Sep; 98(3):689-91. PubMed ID: 17849064
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypofibrinogenaemia resulting from novel single nucleotide deletion at codon Bbeta58 (3404del A) associated with thrombotic stroke in infancy.
    Brennan SO; Mosesson MW; Lowen R; Siebenlist KR; Matsunaga A
    Thromb Haemost; 2006 Apr; 95(4):738-9. PubMed ID: 16601848
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of afibrinogenemia associated with A-alpha chain gene compound heterozygosity (HUMFIBRA c.[4110delA]+[3200+1G>T]).
    Angles-Cano E; Mathonnet F; Dreyfus M; Claeyssens S; de Mazancourt P
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):73-5. PubMed ID: 17179831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A preemptive combined liver-kidney transplantation in Aalpha fibrinogen chain renal amyloidosis].
    Delabre JP; Pageaux GP; Le Quellec A; Raynaud P; Grateau G; Mourad G
    Nephrol Ther; 2009 Apr; 5(2):139-43. PubMed ID: 19013120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel fibrinogen gamma chain mutation (gamma 239 Gln-->His) is the cause of dysfibrinogenemia Vicenza.
    Castaman G; Ghiotto R; Duga S; Rodeghiero F
    J Thromb Haemost; 2005 Mar; 3(3):600-1. PubMed ID: 15748264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.